AMBS OTC
Amarantus BioScience Holdings, Inc.
1W: +0.0%
1M: +9900.0%
3M: +0.0%
YTD: +900.0%
1Y: -66.7%
3Y: -88.9%
5Y: -99.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
+54.7% ▲
Capital Expenditures
$0
-100.0% ▼
Free Cash Flow
-$4M
+54.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$708
-206.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$11M | $18M | -$628K | -$10M | -$5M |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $9M | -$17M | $545K | $269K | $241K |
| Other Non-Cash Items | -$1M | $0 | $0 | $0 | $22K |
| Operating Cash Flow | -$2M | $1M | -$83K | -$10M | -$4M |
| — Investing Activities — | |||||
| Capital Expenditures | -$3K | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | -$2M | $0 | $0 | $0 |
| Investment Sales | $6M | $0 | $0 | $0 | $0 |
| Other Investing | $6K | $0 | -$81K | $10M | $4M |
| Investing Cash Flow | $6M | -$2M | -$81K | $10M | $4M |
| — Financing Activities — | |||||
| Net Debt Issuance | $12M | $913K | $63K | $0 | $0 |
| Stock Repurchased | -$4M | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$16M | $58K | $89K | -$47K | $0 |
| Financing Cash Flow | -$4M | $1M | $163K | -$45K | $0 |
| Net Change in Cash | -$46K | -$121 | -$662 | $662 | -$708 |
| Cash End of Period | $829 | $708 | $46 | $708 | $0 |
| Free Cash Flow | -$2M | $1M | -$83K | -$10M | -$4M |